When IPF fibroblasts were treated with TGF-β1, a 2.5-fold increase in COL3A1 mRNA expression was observed and romidepsin dose-dependently blocked this effect (Figure 3C). Here, COL3A1 is linked to idiopathic pulmonary fibrosis.